{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:44:09Z","timestamp":1791607449492,"version":"4.3.4"},"reference-count":26,"publisher":"Society of Nuclear Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.2967\/jnumed.123.266074","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T10:50:19Z","timestamp":1696503019000},"page":"1889-1894","source":"Crossref","is-referenced-by-count":14,"title":["Chemokine Receptor PET\/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma"],"prefix":"10.2967","volume":"64","author":[{"given":"Johannes","family":"Duell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Hartrampf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Schl\u00f6telburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Schneid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Weich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Dreher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Samnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian E.","family":"Serfling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Rasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max S.","family":"Topp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Kosmala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2023120108101136000_64.12.1889.1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3324\/haematol.2021.278755","article-title":"Marginal zone lymphoma: present status and future perspectives","volume":"107","author":"Cheah","year":"2022","journal-title":"Haematologica."},{"key":"2023120108101136000_64.12.1889.2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol."},{"key":"2023120108101136000_64.12.1889.3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1182\/blood.2021013964","article-title":"PET imaging: back in the game for gastric EMZL?","volume":"139","author":"Cottereau","year":"2022","journal-title":"Blood."},{"key":"2023120108101136000_64.12.1889.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.257279"},{"key":"2023120108101136000_64.12.1889.5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.2152","article-title":"Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis","volume":"33","author":"Treglia","year":"2015","journal-title":"Hematol Oncol."},{"key":"2023120108101136000_64.12.1889.6","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00432-016-2220-6","article-title":"Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin","volume":"142","author":"Stollberg","year":"2016","journal-title":"J Cancer Res Clin Oncol."},{"key":"2023120108101136000_64.12.1889.7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13550-017-0294-z","article-title":"Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities","volume":"7","author":"Herhaus","year":"2017","journal-title":"EJNMMI Res."},{"key":"2023120108101136000_64.12.1889.8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13550-020-00681-7","article-title":"Preliminary evidence of imaging of chemokine receptor-4-targeted PET\/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG","volume":"10","author":"Pan","year":"2020","journal-title":"EJNMMI Res."},{"key":"2023120108101136000_64.12.1889.9","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.7150\/thno.31032","article-title":"Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [68Ga]Ga-Pentixafor-PET\/MRI","volume":"9","author":"Haug","year":"2019","journal-title":"Theranostics."},{"key":"2023120108101136000_64.12.1889.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263693"},{"key":"2023120108101136000_64.12.1889.11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1182\/blood.2021013239","article-title":"CXCR4 PET\/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication","volume":"139","author":"Mayerhoefer","year":"2022","journal-title":"Blood."},{"key":"2023120108101136000_64.12.1889.12","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1007\/s00259-022-05849-y","article-title":"CXCR4-targeted theranostics in oncology","volume":"49","author":"Buck","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023120108101136000_64.12.1889.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264207"},{"key":"2023120108101136000_64.12.1889.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210997"},{"key":"2023120108101136000_64.12.1889.15","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.7150\/thno.19050","article-title":"CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed multiple myeloma","volume":"7","author":"Lapa","year":"2017","journal-title":"Theranostics."},{"key":"2023120108101136000_64.12.1889.16","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3390\/cancers12082333","article-title":"18F-FDG, 11C-methionine, and 68Ga-Pentixafor PET\/CT in patients with smoldering multiple myeloma: imaging pattern and clinical features","volume":"12","author":"Zhou","year":"2020","journal-title":"Cancers (Basel)."},{"key":"2023120108101136000_64.12.1889.17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11307-022-01717-1","article-title":"Impact of tumor burden on normal organ distribution in patients imaged with CXCR4-targeted [68Ga]Ga-pentixafor PET\/CT","volume":"24","author":"Serfling","year":"2022","journal-title":"Mol Imaging Biol."},{"key":"2023120108101136000_64.12.1889.18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/RLU.0000000000004480","article-title":"Impact of 68Ga-FAPI-04 PET\/CT on staging and therapeutic management in patients with digestive system tumors","volume":"48","author":"Kosmala","year":"2023","journal-title":"Clin Nucl Med."},{"key":"2023120108101136000_64.12.1889.19","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1007\/s00259-022-05853-2","article-title":"Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up","volume":"49","author":"Hartrampf","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023120108101136000_64.12.1889.20","doi-asserted-by":"crossref","first-page":"e26932","DOI":"10.1002\/pbc.26932","article-title":"Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection","volume":"65","author":"Ronceray","year":"2018","journal-title":"Pediatr Blood Cancer."},{"key":"2023120108101136000_64.12.1889.21","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.134"},{"key":"2023120108101136000_64.12.1889.22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/bjh.15454","article-title":"High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO","volume":"182","author":"Avivi","year":"2018","journal-title":"Br J Haematol."},{"key":"2023120108101136000_64.12.1889.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00591-X"},{"key":"2023120108101136000_64.12.1889.24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41375-023-01824-0","article-title":"Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma","volume":"37","author":"Leipold","year":"2023","journal-title":"Leukemia."},{"key":"2023120108101136000_64.12.1889.25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11307-019-01375-w","article-title":"Semiquantitative parameters in PSMA-targeted PET imaging with [18F]DCFPyL: impact of tumor burden on normal organ uptake","volume":"22","author":"Werner","year":"2020","journal-title":"Mol Imaging Biol."},{"key":"2023120108101136000_64.12.1889.26","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.3390\/cancers14112609","article-title":"Associations between normal organs and tumor burden in patients imaged with fibroblast activation protein inhibitor-directed positron emission tomography","volume":"14","author":"Kosmala","year":"2022","journal-title":"Cancers (Basel)."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.266074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T11:12:15Z","timestamp":1701429135000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.266074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,1]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.2967\/jnumed.123.266074"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.266074","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}